GAB2 was expressed at higher levels in metastatic melanoma than in primary melanoma, and it could enhance the invasiveness of melanoma cells by inhibiting the PI3K-Akt pathway (Horst et al., 2009). The gene discussed is GAB2; the disease is metastatic melanoma.